Advertisement

Re-Treatment of Chronic Pulmonary Tuberculosis with Low and High Dosages Rifampicin Regimens in the Continuation Intermittent Phase (A controlled comparison study)

  • M. Zierski
  • E. Bek
  • J. Marcinia
  • B. Szelagowicz
Part of the Chemotherapy book series (CT, volume 3)

Abstract

The great value of rifampicin as a suitable anti-tuberculous agent for intermittent therapy has been confirmed in several experimental and clinical studies. Unfortunately our actual knowledge of which size of doses should be chosen for rifampicin in the intermittent therapy after a preceding daily phase is still insufficient.

Keywords

Pulmonary Tuberculosis Intermittent Therapy Bacteriological Result Intermittent Regimen Total Effectivity 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Plenum Press, New York 1976

Authors and Affiliations

  • M. Zierski
    • 1
  • E. Bek
    • 1
  • J. Marcinia
    • 2
  • B. Szelagowicz
    • 2
  1. 1.Department of Respiratory Diseases and TuberculosisNational Institute for Research of Tuberculosis Study CentreLodzPoland
  2. 2.District Chest DispensaryPoznanPoland

Personalised recommendations